Skip to content

Apelin and Adiponectin levels in patients with periodontal disease and hypertension and its relation to cognition before and after ultrasonic scaling.

Apelin and Adiponectin and their relation to periodontal disease, hypertension and cognition before and after scaling and root planning - An observational study. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/092801
Enrollment
80
Registered
2025-08-11
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

Intervention1: Scaling and root planing: Salivary and serum Apelin and Adiponectin levels, neuropsychological assessment and clinical parameters will be assessed at baseline and four weeks post scalin

Sponsors

Dr Chatragadda Swathi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients who have not received any periodontal treatment in the previous six months. 2.Patients with a diagnosis of generalized periodontitis as per World Workshop Classification criteria (2017) 3.Patients diagnosed with Hypertension as per the American College of Cardiology (ACC) and American Heart Association (AHA) guidelines (2017).

Exclusion criteria

Exclusion criteria: 1.Smokers and alcoholics. 2.Patients with systemic diseases like diabetes mellitus, cardiovascular diseases, rheumatoid arthritis, tumors, autoimmune diseases and renal diseases. 3.Pregnant and lactating females. 4.Any other systemic disease which can alter the course of periodontal disease. 5.Patients on medications like anti-inflammatory drugs, antibiotics and anti-epileptic drugs in the past 6 months. 6.Postmenopausal women.

Design outcomes

Primary

MeasureTime frame
To correlate levels of salivary & serum Apelin and Adiponectin in individuals with generalised periodontitis and Hypertension.Timepoint: At baseline and four weeks after scaling and root planing

Secondary

MeasureTime frame
To evaluate the effect of scaling and root planing on periodontal health, hypertension and cognition.Timepoint: At baseline and four weeks after scaling and root planing

Countries

India

Contacts

Public ContactDr Ashish S Nichani

The Oxford Dental college

nichaniashish@hotmail.com9845252203

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026